Filing Flows

Filing Flows › Adma Biologics (ADMA) › Who owns the stock

Who owns Adma Biologics (ADMA) stock

317 funds reported Adma Biologics (ADMA) shares in their latest 13F filings, worth $2.1B in all. The largest holder is Vanguard Group ($380M). Last quarter 127 funds added to their stakes and 204 cut them.

Largest holders of ADMA (13F)Largest holders of ADMA (13F)Vanguard Group$380MBlackRock$321MState Street$143MVanguard Capital Management LLC$84.6MVanguard Portfolio Management LLC$84.4MRubric Capital Management LP$78.2MCapital Research Global Investors$73.3MFirst Trust Advisors LP$65.3MGeode Capital Management, LLC$50.7MCaligan Partners LP$47.9M

Largest holders (13F)

FundSharesValueChangeQuarter
Vanguard Group20,854,669$380Mdecrease2025-12-31
BlackRock38,355,684$321Mincrease2026-06-30
State Street17,116,022$143Mincrease2026-06-30
Vanguard Capital Management LLC10,103,809$84.6Mdecrease2026-06-30
Vanguard Portfolio Management LLC10,088,490$84.4Mincrease2026-06-30
Rubric Capital Management LP9,339,414$78.2Mincrease2026-06-30
Capital Research Global Investors8,756,374$73.3Mdecrease2026-06-30
First Trust Advisors LP7,798,351$65.3Mincrease2026-06-30
Geode Capital Management, LLC6,059,984$50.7Mincrease2026-06-30
Caligan Partners LP5,725,007$47.9Mincrease2026-06-30
D. E. Shaw5,274,597$44.1Mincrease2026-06-30
Nantahala Capital Management, LLC4,719,986$39.5Mnew2026-06-30
Dimensional Fund Advisors LP3,606,208$30.2Mdecrease2026-06-30
Goldman Sachs Group3,513,583$29.4Mincrease2026-06-30
B Group3,262,542$27.3Mincrease2026-06-30

Adma Biologics' latest quarter

Adma Biologics, Q3 2026: revenue $141M (+5% year over year), operating margin 48.0%, net earnings $49.9M, operating cash flow $17.4M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most ADMA stock?

By the latest 13F filings: Vanguard Group ($380M); BlackRock ($321M); State Street ($143M); Vanguard Capital Management LLC ($84.6M); Vanguard Portfolio Management LLC ($84.4M).

What is the short interest in ADMA?

19,528,063 shares were sold short at the 2026-10-15 settlement, -5.19% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.